SCHEMBL4816909

SCHEMBL4816909

CCOc1cc(C(=O)c2ccc(N(C)C)cc2)ccc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.62
PDE4B Q07343 5/20 0.62
PDE4C Q08493 5/20 0.62
PDE4D Q08499 5/20 0.62
MAPK1 P28482 1/20 0.57
TSHR P16473 3/20 0.57
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2C19 P33261 2/20 0.57
CYP2C9 P11712 1/20 0.57
ACHE P22303 5/20 0.54
ALDH1A1 P00352 2/20 0.54
GAA P10253 1/20 0.54
TP53 P04637 1/20 0.53
MAPT P10636 2/20 0.53
HPGD P15428 1/20 0.53
NPC1 O15118 1/20 0.52
USP2 O75604 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826029 0.88 TSHR (0.72) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL5076592 0.87 TSHR (0.76) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL5077500 0.84 LMNA (0.63) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL4825956 0.81 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL4826406 0.81 PDE4A (0.76) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL4824742 0.81 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL4822545 0.80 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL4824589 0.80 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL20496433 0.80 NPC1 (0.71) MAPK1TSHRCYP1A2CYP3A4CYP2C19
SCHEMBL7254762 0.78 ALDH1A1 (0.76) MAPK1TSHRCYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470723-B2 Diphenylethylene compounds and uses thereof CELGENE CORPORATION (US) 2008-12-30 US disclosed
EP-1799634-A2 DIPHENYLETHYLENE COMPOUNDS AND USES THEREOF CELGENE CORPORATION (US) 2007-06-27 EP disclosed
WO-2006026747-A2 DIPHENYLETHYLENE COMPOUNDS AND USES THEREOF CELGENE CORPORATION (US) 2006-03-09 WO disclosed
US-20050107339-A1 Diphenylethylene compounds and uses thereof CELGENE CORPORATION 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107339-A1 Diphenylethylene compounds and uses thereof VHL, TNF, PTGES PDE4A 2547/4885PDE4B 2484/4885PDE4C 2542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.